1. P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. (21st February 2018) Authors: Emery, P; Taylor, PC; Weinblatt, ME; Tanaka, Y; Keystone, EC; Dow, ER; Higgs, R; Macias, WL; Rocha, G; Rooney, TP; Schlichting, DE; Zuckerman, SH; McInnes, IB; Holzkaemper, T Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗